CLDN18 and gastric cancer: In cases of intestinal‐type GC tumors, gene fusions involving ARHGAP26, PKN1, and PRKCA (specifically CLDN18:ARHGAP26, ZNF791:PKN1, and MSI2:PRKCA) were identified in 5.9% (n = 17) of the cases.